|Mr. Matthew Dudek||Acting Chief Exec. Officer||636.27k||N/A||N/A|
|Mr. Dominic Burg||Chief Operating Officer||N/A||N/A||N/A|
|Ms. Carolyn Heath||Chief Customer Officer & GM of Sales||N/A||N/A||N/A|
|Dr. Graham Robertson||Head of R&D||N/A||N/A||N/A|
|Mr. Scott Mitchell Greasley||Exec. Director||N/A||N/A||N/A|
|Mr. Lee Tamplin B.A.||Company Sec.||N/A||N/A||N/A|
Anagenics Limited operates as a health and beauty-tech company in Australia, New Zealand, Japan, and internationally. The company develops and sales FGF5 inhibitor hair health and hair growth products under the evolis, evolis Professional, Lexilis Hybrid, Jo-Ju RED, and Lexilis BLACK brands. It markets its products through various channels, including e-commerce, television shopping, wholesale pharmacy and salons, and cross border export markets. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.
Anagenics Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.